Galderma Group AG (GALDY)
41.59
-0.05
(-0.12%)
USD |
OTCM |
Jun 09, 16:00
Galderma Group 1 Year Total Returns (Daily) : 48.24% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 48.24% |
| June 08, 2026 | 46.85% |
| June 05, 2026 | 48.19% |
| June 04, 2026 | 49.48% |
| June 03, 2026 | 50.27% |
| June 02, 2026 | 52.69% |
| June 01, 2026 | 57.38% |
| May 29, 2026 | 70.54% |
| May 28, 2026 | 63.33% |
| May 27, 2026 | 63.54% |
| May 26, 2026 | 60.43% |
| May 22, 2026 | 58.42% |
| May 21, 2026 | 63.93% |
| May 20, 2026 | 66.50% |
| May 19, 2026 | 60.09% |
| May 18, 2026 | 64.25% |
| May 15, 2026 | 71.33% |
| May 14, 2026 | 75.67% |
| May 13, 2026 | 73.31% |
| May 12, 2026 | 70.90% |
| May 11, 2026 | 73.84% |
| May 08, 2026 | 80.61% |
| May 07, 2026 | 80.26% |
| May 06, 2026 | 84.83% |
| May 05, 2026 | 74.82% |
| Date | Value |
|---|---|
| May 04, 2026 | 72.45% |
| May 01, 2026 | 73.61% |
| April 30, 2026 | 73.48% |
| April 29, 2026 | 69.57% |
| April 28, 2026 | 76.00% |
| April 27, 2026 | 84.29% |
| April 24, 2026 | 93.37% |
| April 23, 2026 | 103.3% |
| April 22, 2026 | 94.08% |
| April 21, 2026 | 94.19% |
| April 20, 2026 | 103.3% |
| April 17, 2026 | 103.2% |
| April 16, 2026 | 99.25% |
| April 15, 2026 | 104.3% |
| April 14, 2026 | 110.3% |
| April 13, 2026 | 111.1% |
| April 10, 2026 | 109.5% |
| April 09, 2026 | 116.4% |
| April 08, 2026 | 117.8% |
| April 07, 2026 | 109.8% |
| April 06, 2026 | 111.8% |
| April 02, 2026 | 83.81% |
| April 01, 2026 | 82.72% |
| March 31, 2026 | 76.27% |
| March 30, 2026 | 70.74% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Sandoz Group AG | 53.78% |
| Novartis AG | 30.20% |
| Roche Holding AG | 26.76% |
| Addex Therapeutics Ltd. | -38.04% |
| Oculis Holding AG | -44.87% |